arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

CareDx, Inc.

CDNA Health Care Medical Specialities
$69.16
▼ -0.1% Today
as of Oct 22, 16:47 ET
Last 30 days +32.06% Sep 14 → Oct 22
$50.90 $56.23 $61.55 $66.88 $72.21 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$69.65
High
$71.51
Low
$66.85
Volume
$917,720
Avg Vol
$947,750
Mkt Cap
$3.3B
P/E (TTM)
29.77
Beta
—
52w High
$72.71
52w Low
$14.03
Div Yield
—
Shares Out
$51M

Recent Press Releases & News last 60 days · 10 items

Oct 22 · 11:05 PR Business Wire
CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026
Oct 15 · 20:01 PR Business Wire
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
Oct 10 · 00:20 Simply Wall St.
CareDx (CDNA) Stock Gets Fair Value Bump After Reimbursement And Analyst Target Changes
▸ Show all 10 press releases & news Free account →

CDNA earnings at a glance

CareDx, Inc. (CDNA) is scheduled to report earnings on Tuesday, November 3, 2026 — in 11 days. Analysts expect earnings per share of $0.07, compared with $0.03 in the same quarter last year (+133%). The options market is pricing a move of about ±8.3% after the report, a range of roughly $63.43 to $74.89 from today's $69.16. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±9.0% on average; after the most recent report on Jul 30, 2026 it moved +14.7%. That means options currently expect about the same movement than CDNA has typically delivered. CDNA beat the consensus EPS estimate in 4 of its last 5 reported quarters. Implied volatility is currently 70%. The share price of $69.16 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$14
$73
94% of range
Avg surprise (last 5)
+84.0%
Avg reaction (last 6)
+1.1%
50% positive
Latest IV / EM
70%
EM ±8.3% · $60 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.46$-0.30$-0.15$0.01$0.17 Actual $-0.44Actual $-0.46Actual $-0.43Actual $-0.38Actual $-0.09Actual $-0.20Actual $-0.19Est $-0.21Actual $-0.16Est $-0.11Actual $0.03Est $-0.11Actual $-0.08Actual $0.05Est $-0.11Actual $0.17Est $0.06 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-11M$27M$64M$101M$139M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 30, 2026Jun/2026 $0.17 $0.06 +183.3% +137.5% +14.7% earnings
Tue Apr 28, 20268K 2026-04-28 $0.05 $-0.11 +145.4% — -5.1% earnings
Wed Feb 25, 20268K 2026-02-25 $-0.08 — — — +1.9% earnings
Tue Nov 4, 2025Sep/2025 $0.03 $-0.11 +127.3% — +13.8% earnings
Wed Aug 6, 2025Jun/2025 $-0.16 $-0.11 -45.5% — -7.9% earnings
Wed Apr 30, 2025Mar/2025 $-0.19 $-0.21 +9.5% — -10.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.20 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.09 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.43 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.46 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.44 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Nov 3, 2026Sep/2026OTHER $0.07$0.03 +133.3%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$132M$118M—$100M$87M$85M—$83M
Cost of revenue————————
Gross profit————————
Operating income$113M$1M—$-246,000$-11M$-13M—$-14M
Net income$111M$3M—$2M$-9M$-10M—$-11M
EPS (diluted)$2.07$0.05—$0.03$-0.16$-0.19—$-0.20

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$374M$78M$65M$91M$68M$89M$115M$95M
Inventory$7M$26M$27M$28M$28M$23M$20M$19M
Total current assets$429M$269M$257M$300M$307M$350M$352M$334M
Total assets$533M$411M$413M$432M$444M$490M$491M$477M
Long-term debt———————$0
Total liabilities$107M$98M$110M$121M$117M$110M$113M$204M
Total equity$426M$314M$303M$311M$327M$379M$378M$273M

Implied volatility — last 90 days

34%89%145%200%256% Jun 09 — IV 88% · EM ±11.0%Jun 10 — IV 179% · EM ±21.1%Jun 11 — IV 189% · EM ±20.9%Jun 12 — IV 206% · EM ±21.1%Jun 15 — IV 256% · EM ±18.6%Jun 16 — IV 80% · EM ±4.8%Jun 19 — IV 83% · EM ±18.3%Jun 22 — IV 90% · EM ±18.8%Jun 23 — IV 79% · EM ±16.1%Jun 24 — IV 113% · EM ±22.7%Jun 25 — IV 84% · EM ±16.4%Jun 26 — IV 80% · EM ±15.3%Jun 29 — IV 96% · EM ±17.1%Jun 30 — IV 107% · EM ±18.4%Jul 01 — IV 126% · EM ±21.0%Jul 02 — IV 101% · EM ±16.4%Jul 03 — IV 105% · EM ±16.4%Jul 06 — IV 127% · EM ±17.6%Jul 08 — IV 178% · EM ±22.3%Jul 09 — IV 160% · EM ±18.9%Jul 10 — IV 159% · EM ±17.5%Jul 13 — IV 137% · EM ±11.5%Jul 14 — IV 248% · EM ±18.0%Jul 16 — IV 72% · EM ±3.0%Jul 20 — IV 74% · EM ±17.4%Jul 21 — IV 67% · EM ±15.6%Jul 22 — IV 65% · EM ±14.9%Jul 23 — IV 99% · EM ±22.3%Jul 24 — IV 76% · EM ±16.9%Jul 27 — IV 86% · EM ±17.9%Jul 28 — IV 83% · EM ±17.1%Jul 29 — IV 79% · EM ±15.9%Jul 30 — IV 67% · EM ±13.2%Jul 31 — IV 54% · EM ±10.3%Aug 03 — IV 36% · EM ±6.3%Aug 04 — IV 48% · EM ±8.2%Aug 05 — IV 43% · EM ±7.2%Aug 06 — IV 39% · EM ±6.3%Aug 07 — IV 48% · EM ±7.5%Aug 10 — IV 84% · EM ±11.7%Aug 11 — IV 103% · EM ±13.6%Aug 12 — IV 98% · EM ±12.3%Aug 13 — IV 98% · EM ±11.6%Aug 14 — IV 37% · EM ±4.1%Aug 18 — IV 72% · EM ±5.2%Aug 19 — IV 177% · EM ±10.4%Aug 24 — IV 75% · EM ±15.6%Aug 25 — IV 47% · EM ±9.5%Aug 26 — IV 40% · EM ±8.1%Aug 27 — IV 49% · EM ±9.6%Aug 28 — IV 41% · EM ±7.8%Aug 31 — IV 59% · EM ±10.4%Sep 01 — IV 58% · EM ±10.0%Sep 02 — IV 34% · EM ±5.7%Sep 03 — IV 37% · EM ±6.0%Sep 04 — IV 44% · EM ±6.9%Sep 07 — IV 50% · EM ±6.9%Sep 08 — IV 36% · EM ±4.8%Sep 09 — IV 38% · EM ±4.8%Sep 10 — IV 52% · EM ±6.1%Sep 14 — IV 134% · EM ±11.2%Sep 15 — IV 155% · EM ±11.2%Sep 21 — IV 48% · EM ±10.1%Sep 22 — IV 45% · EM ±9.2%Sep 23 — IV 39% · EM ±7.8%Sep 24 — IV 42% · EM ±8.3%Sep 25 — IV 53% · EM ±10.1%Sep 28 — IV 55% · EM ±9.7%Sep 29 — IV 61% · EM ±10.5%Sep 30 — IV 58% · EM ±9.8%Oct 01 — IV 67% · EM ±10.8%Oct 02 — IV 60% · EM ±9.3%Oct 06 — IV 67% · EM ±8.8%Oct 07 — IV 72% · EM ±9.0%Oct 08 — IV 70% · EM ±8.3%

Sector peers

VCYT
Veracyte, Inc.
$3.5B $46.04+2.8%
CELC
Celcuity Inc.
$3.7B $65.57+9.3%
ACHC
Acadia Healthcare Company, Inc.
$2.7B $31.88+1.4%
CLOV
Clover Health Investments, Corp.
$2.4B $4.73-1.5%
VRDN
Viridian Therapeutics, Inc.
$2.1B $22.82+1.7%
FTRE
Fortrea Holdings Inc.
$2.0B $23.92+5.0%

CDNA earnings FAQ

When is CDNA's next earnings date?

CareDx, Inc. is expected to report on November 3, 2026.

What is CDNA's expected move for earnings?

Options currently price a move of about ±8.3%, or $5.73 per share either way from $69.16.

How does CDNA stock usually react to earnings?

Across the last 6 reports the average next-day move was ±9.0%, up 3 times and down 3 times.

What EPS are analysts expecting from CareDx, Inc.?

The consensus estimate is $0.07 per share, versus $0.03 a year ago.

What is CDNA's implied volatility?

CDNA's at-the-money implied volatility is about 70% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in